| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10137714 | Regulatory Toxicology and Pharmacology | 2018 | 4 Pages |
Abstract
The present paper links poor-quality antimicrobials and AMR, highlighting examples of regulatory initiatives on this subject outside the EU, particularly those resulting from the World Health Organization (WHO) recommendations. It also intends to trigger a discussion on the role of such quality control programmes, particularly for antimicrobials, beyond the control at any stage of the quality parameters of a marketed medicine, to reflect whether or not it might be relevant to other regulatory coordinated actions against AMR.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Helena Ponte, Rui Santos Ivo, Beatriz Silva-Lima, Fernando Ramos,